Results 231 to 240 of about 253,625 (250)

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

Annals of Oncology, 2017
R E Coleman, S I Helle, Joe M O'Sullivan   +2 more
exaly  

LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3

Annals of Oncology
S. Gillessen, A. Choudhury, F. Saad, E. Gallardo, A. Soares, Y. Loriot, R. McDermott, A. Rodríguez-Vida, P. Isaacson, F. Nolè, F.J.S. Melo Cruz, T. Roumeguere, K.G. Daugaard, R. Yamamura, F. Lecouvet, C. Coens, B. Fournier, B. Tombal   +17 more
semanticscholar   +1 more source

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

Annals of Oncology, 2016
O Sartor, N J Vogelzang, R E Coleman
exaly  

Radium-223 dichloride

2023
Charisma DeSai, Yaïr Glick
openaire   +1 more source

Evaluating response to radium-223 using 68Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer

Annals of Nuclear Medicine
Q. Shagera, Thierry Gil, Elisa Barraco, Petra Boegner, P. Kristanto, Ziad El Ali, S. Sideris, N. Martínez Chanzá, T. Roumeguère, P. Flamen, C. Artigas   +10 more
semanticscholar   +1 more source

Radium-223-chloride

Reactions Weekly, 2016
  +4 more sources

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Annals of Oncology, 2017
M J Méndez Vidal, Giuseppe Procopio, E Rosenbaum   +2 more
exaly  

Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer

European Journal of Cancer, 2020
Maarten J Van Der Doelen, Pedro Isaacsson Velho, Peter H J Slootbeek   +2 more
exaly  

Radium-223-chloride

Reactions Weekly, 2020
openaire   +1 more source

Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial

European Journal of Cancer, 2017
Christopher Parker, Lin Zhan, Nicholas J Vogelzang   +2 more
exaly